Browse by author
Lookup NU author(s): Dr Bruce Charlton
The fundamental methodological deficiency of megatrials is deliberate reduction of experimental control in order to maximize recruitment and compliance of subjects. Hence, typical megatrials recruit pathologically and prognostically heterogeneous subjects, and protocols typically fail to exclude significant confounders. Therefore, most megatrials do not test a scientific hypothesis, nor are they informative about individual patients. The proper function of a megatrial is precise measurement of effect size for a therapeutic intervention. Valid megatrials can be designed only when simplification can be achieved without significantly affecting experimental control. Megatrials should be conducted only at the end of a long process of therapeutic development, and must always be designed and interpreted in the context of relevant scientific and clinical information.
Author(s): Charlton BG
Publication type: Article
Publication status: Published
Journal: Current Controlled Trials in Cardiovascular Medicine
Year: 2001
Volume: 2
Issue: 1
Pages: 2-7
Date deposited: 26/02/2008
ISSN (print): 1468-6708
ISSN (electronic): 1745-6215
Publisher: BioMed Central Ltd.
URL: http://dx.doi.org/10.1186/cvm-2-1-002
DOI: 10.1186/cvm-2-1-002
Altmetrics provided by Altmetric